Future Cardiology

β-adrenergic receptor pharmacogenetics
pp. 229-232(4)
Author: Cavallari, Larisa H

Percutaneous coronary interventions: benefit, risk and cost-effectiveness
pp. 233-234(2)
Authors: Dieter, Robert S; Nanjundappa, Aravinda

Study fails to validate genetic risk factors for ACS
pp. 235-237(3)

Double jeopardy for the mentally ill: higher cardiovascular risk and reduced frequency of certain interventional procedures
pp. 239-242(4)
Author: L'Italien, Gilbert j

Can intense exercise contribute to cardiovascular disease?
pp. 243-248(6)
Authors: Majeed, Farhan; Miller, Michael

Validation of the human tissue factor/FVIIa complex as an antithrombotic target and the discovery of a synthetic peptide
pp. 249-262(14)
Authors: Sakariassen, Kjell S; Örning, Lars

γ-glutamyltransferase and pathogenesis of cardiovascular diseases
pp. 263-270(8)
Authors: Emdin, Michele; Passino, Claudio; Franzini, Maria; Paolicchi, Aldo; Pompella, Alfonso

Visceral debranching to facilitate repair of complex thoracic and thoracoabdominal aneurysms
pp. 271-281(11)
Author: Kasirajan, Karthik

Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease
pp. 283-300(18)
Author: Khalil, Raouf A

Anticoagulant therapy in acute coronary syndromes
pp. 301-308(8)
Author: Bates, Eric R

Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides
pp. 309-319(11)
Authors: Yu, Roger; Navab, Mohamad

Vitamin K antagonist use in the elderly: special considerations
pp. 321-330(10)
Authors: Siguret, Virginie; Pautas, Eric; Gouin-Thibault, Isabelle